相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-Acid Fluid Exposure and Esophageal Squamous Cell Carcinoma
Ali Soroush et al.
DIGESTIVE DISEASES AND SCIENCES (2022)
Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study
Jeremy P. Brown et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Ranitidine Use and Risk of Upper Gastrointestinal Cancers
Hans-Olov Adami et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Do proton pump inhibitors prevent Barrett's esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis
Yue Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Amitriptyline functionally antagonizes cardiac H2 histamine receptors in transgenic mice and human atria
Joachim Neumann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)
2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease
Hye-Kyung Jung et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2021)
The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions
Joachim Neumann et al.
FRONTIERS IN PHARMACOLOGY (2021)
Rheumatoid arthritis and neurodegenerative dementia: a nested case-control study and a follow-up study using a national sample cohort
Chanyang Min et al.
CLINICAL RHEUMATOLOGY (2020)
Bidirectional Association Between GERD and Asthma: Two Longitudinal Follow-Up Studies Using a National Sample Cohort
So Young Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Bell's palsy and obesity, alcohol consumption and smoking: A nested case-control study using a national health screening cohort
So Young Kim et al.
SCIENTIFIC REPORTS (2020)
Overlap Weighting A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial
Laine E. Thomas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
Hong Kyu Lee et al.
DIAGNOSTIC PATHOLOGY (2020)
Addressing Extreme Propensity Scores via the Overlap Weights
Fan Li et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2019)
Tobacco Smoking and Alcohol Consumption Are Related to Benign Parotid Tumor: A Nested Case-Control Study Using a National Health Screening Cohort
So Young Kim et al.
CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY (2019)
Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans
M. C. Tan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Maintenance proton pump inhibition therapy and risk of oesophageal cancer
Nele Brusselaers et al.
CANCER EPIDEMIOLOGY (2018)
Proton pump inhibitor use and cancer mortality
Siri A. Tvingsholm et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus
Yoomi Lee et al.
ONCOTARGET (2017)
Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study
Prashanthi N. Thota et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial
Michael P. Chu et al.
JAMA ONCOLOGY (2017)
Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis
Qiang Hu et al.
PLOS ONE (2017)
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
S. H. Lim et al.
EUROPEAN JOURNAL OF CANCER (2016)
Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastric pH in extensive metabolizer patients with gastroesophageal reflux disease
Altay Celebi et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2016)
Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells
Eduardo Chueca et al.
FRONTIERS IN PHARMACOLOGY (2016)
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus
Y. Aydin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients
F. Hvid-Jensen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis
Siddharth Singh et al.
GUT (2014)
Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus
Florine Kastelein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Impact of Endoscopic Surveillance on Mortality From Barrett's Esophagus-Associated Esophageal Adenocarcinomas
Douglas A. Corley et al.
GASTROENTEROLOGY (2013)
Epidemiology of esophageal cancer
Yuwei Zhang
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Atorvastatin correlates with decreased risk of esophageal cancer: a population-based case-control study from Taiwan
Shih-Wei Lai et al.
LIBYAN JOURNAL OF MEDICINE (2012)
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
Hude Quan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma
Sachin Wani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Omeprazole Inhibits Proliferation and Modulates Autophagy in Pancreatic Cancer Cells
Andrej Udelnow et al.
PLOS ONE (2011)
Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
GASTROENTEROLOGY (2010)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shaojun Shi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors
M. R. Namazi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2008)
Gastroesophageal reflux disease: An Asian perspective
Justin C. Y. Wu
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
L. A. Garcia Rodriguez et al.
GUT (2006)
Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
LC Hillman et al.
MEDICAL JOURNAL OF AUSTRALIA (2004)
Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus
HB El-Serag et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Proton pump inhibitors - differences emerge in hepatic metabolism
KEL McColl et al.
DIGESTIVE AND LIVER DISEASE (2002)
分享论文
